Back to Search
JOHN PINSKI, M.D.
M.D.
Urology Physician
NPI: 1316911779IndividualAccepts Medicare
Specialties, Licenses & Credentials
Urology PhysicianPrimary
Urology
Code: 208800000X
160669-1(NY)
CMS Specialties
PrimaryUROLOGY
Education
OTHER
Class of 1983
Research & Publications (20)
Gene profiling and pathway analysis of neuroendocrine transdifferentiated prostate cancer cells.
PMID 18814146·Prostate·2009
8-other
Oral fenretinide in biochemically recurrent prostate cancer: a California cancer consortium phase II trial.
PMID 19213668·Clin Genitourin Cancer·2009
3-trial
Both beta-actin and GAPDH are useful reference genes for normalization of quantitative RT-PCR in human FFPE tissue samples of prostate cancer.
PMID 18651557·Prostate·2008
8-other
A phase II study of high-dose calcitriol combined with mitoxantrone and prednisone for androgen-independent prostate cancer.
PMID 18782306·BJU Int·2008
3-trial
The AKT inhibitor perifosine in biochemically recurrent prostate cancer: a phase II California/Pittsburgh cancer consortium trial.
PMID 18272025·Clin Genitourin Cancer·2007
3-trial
Glucose-regulated protein GRP78 is up-regulated in prostate cancer and correlates with recurrence and survival.
PMID 17640713·Hum Pathol·2007
8-other
Evolving treatment paradigms for locally advanced and metastatic prostate cancer.
PMID 17134367·Expert Rev Anticancer Ther·2006
6-review
Locus-wide chromatin remodeling and enhanced androgen receptor-mediated transcription in recurrent prostate tumor cells.
PMID 16980632·Mol Cell Biol·2006
7-preclinical
Prognostic significance of neuroendocrine expression in lymph node-positive prostate cancer.
PMID 16697447·Urology·2006
8-other
Genistein-induced neuroendocrine differentiation of prostate cancer cells.
PMID 16652383·Prostate·2006
8-other
Postchemotherapy residual masses in advanced seminoma: current management and outcomes.
PMID 16221056·Expert Rev Anticancer Ther·2005
6-review
Discovery and preclinical evaluation of a novel class of small-molecule compounds in hormone-dependent and -independent cancer cell lines.
PMID 16020668·Mol Cancer Ther·2005
7-preclinical
EphB4 expression and biological significance in prostate cancer.
PMID 15930280·Cancer Res·2005
7-preclinical
Ethnic differences in neuroendocrine cell expression in normal human prostatic tissue.
PMID 15882754·Urology·2005
4-observational
Prostate cancer metastases to bone: pathophysiology, pain management, and the promise of targeted therapy.
PMID 15808959·Eur J Cancer·2005
6-review
Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results.
PMID 15538242·J Urol·2004
8-other
Inhibitory effect of IL-6-induced neuroendocrine cells on prostate cancer cell proliferation.
PMID 15368468·Prostate·2004
8-other
Interleukin-6 inhibits the growth of prostate cancer xenografts in mice by the process of neuroendocrine differentiation.
PMID 15239127·Int J Cancer·2004
4-observational
A new screening system for proliferation-independent anti-cancer agents.
PMID 15172129·Cancer Lett·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3085 HARLEM ROAD, SUITE 200
CHEEKTOWAGA, NY 14225 - Phone
- (716) 844-5000
Quick Facts
- NPI
- 1316911779
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 43
- Publications
- 20
Are you this provider?
Claim Your Profile